Navigation Links
Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
Date:4/9/2008

data points fall within the A/B region, along with negligible or no D/E points. MARD is an error calculation tool that was used to measure the average relative difference between Symphony and the reference measurements, on a percentage basis. A low MARD error, below 20%, is generally accepted to be consistent with an accurate device.

Study Results

Using nearly 144 hours of continuous data from Symphony and 183 reference BG measurements from the 6 study subjects in a home use setting with self-administration, Clarke Error Grid analysis of the study data showed that Symphony had 100% of the data in the combined A and B regions with approximately 90% in the "A" region. No data points showed in the C, D and E regions. The MARD for the study was 9.0%. There were no Prelude or Symphony failures and no adverse events, indicating strong reliability of Prelude as the skin permeation medium for Symphony.

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for people with diabetes and for use in hospital critical care units, together with a wide range of novel transdermal reformulations of FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies regarding the efficacy of Echo's tCGM systems (including the Symphony
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... FRANCISCO , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... Howard W. Robin , is scheduled to present ... New York at the Sheraton New York ... time. The presentation will be accessible via a ... Calendar section of the Nektar website: http://www.nektar.com . This ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Similar to Seven-Day in, Achieving Red Blood Cell Transfusion Independence, ... ... Data Presented at the 49th American Society of Hematology (ASH) ... ) today announced interim data from a Phase 2 clinical ...
... of Severe Cardiac Toxicity With Equivalent ... Complete Remission Rates ... (Nasdaq and MTAX: CTIC) announced today that preliminary data ... in the,first-line treatment of patients with aggressive non-Hodgkin,s lymphoma,(NHL) ...
Cached Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
(Date:5/20/2013)... May 20, 2013 Healing Heart Urgent ... newest office on Briarcliff Road in the Druid Hills ... facility includes Dr. Fidias E. De León M.D. and ... will provide extensive medical services, occupational health, chiropractic care ... Atlanta metropolitan area. They also offer a full range ...
(Date:5/20/2013)... 20, 2013 AURORA, Colo. – May ... accredited university, has developed a Bachelor of Science ... how they feel about continuing their education and gauge ... out the complimentary worksheet, respond to ten statements and ... rate on a BSN-readiness scale. , New industry standards ...
(Date:5/20/2013)... NY (PRWEB) May 20, 2013 InVite® ... City, today announced the introduction of its new ... that provides high density nutrition with plant extracts from ... herbs, spices, royal jelly, apple pectin, plant enzymes and ... offers the micronutrients and antioxidant levels of several servings ...
(Date:5/20/2013)... Can you tell a joke well? , Do people roll their ... like to be funnier as a speaker, teacher, presenter of any ... missing? , Can't think of a snappy comeback when someone hits ... like you, don't worry. Help is here. I believe ... even learn to tell a joke well. I am not kidding. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...
Breaking Medicine News(10 mins):Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3
... , , , ... has been invited to participate in the inaugural Australian Paralympic ... basketball team includes nine athletes and three coaches from Courage ... 5-11 at the Melbourne Sports & Aquatic Centre. The Paralympic ...
... , WASHINGTON, Sept. 23 Speaker Nancy ... Legislative Conference "Capitol Hill Day Summit" this morning in the Capitol ... , , "Thank you, Chairwoman Barbara ... conscience of the Congress. , , "Essential ...
... , STAMFORD, Conn., Sept. 23 AmeriCares this ... States at the 2009 Clinton Global Initiative in New York ... CEO Curt Welling, is a two-year commitment to improve community ... organizations serving the uninsured and underinsured throughout the country. ...
... , , , ... announces their Second Annual Fellowship Convention to be held at ... California. , , Founded in 1998, FA is ... support, are recovering from food addiction. For many people who ...
... series of cases with commentaries by the American ... Rights Committee and the College,s Center for Ethics ... http://cme.medscape.com/viewpublication/30131. "The ethical dilemmas presented are very ... MD, FACP, ACP President. "Learning from case studies ...
... capsules that show a tendency in the standard laboratory test ... and potentially unsafe manner in patients who have consumed alcohol ... with testing in people. That,s the conclusion of a ... Molecular Pharmaceutics , a bi-monthly journal. In ...
Cached Medicine News:Health News:12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team 2Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 2Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 3Health News:AmeriCares Expands Medical Assistance Across the United States 2Health News:AmeriCares Expands Medical Assistance Across the United States 3Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 2Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 3
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
... Biotech Uni-Gold™ Pf Malaria Test is ... the presence of Plasmodium falciparum ... is an antigen-capture assay detecting presence ... rich protein II (PfHRP- II), which ...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: